Expert Rev Mol Diagn. 2010;10(1):49-64. With the ultimate goal of enabling personalized medicine for PC, massive efforts have been undertaken to identify new and better diagnostic, prognostic and ...
SOX2 is a member of SOX (SRY-related high mobility group box) family of transcription factors. We found that SOX2 was expressed in murine prostates during budding morphogenesis and in neuroendocrine ...
Table 1 Clinico-pathological characteristics and selection criteria for high and normal BMI prostate cancer patients Gene expression features were normalized by using RMAExpress and by ChipInspector ...
The core foundation of precision medicine, and in turn, precision oncology, is a personalized approach to treatment that focuses on targeting specific molecular features that impact how cancer cells ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that its market-leading Decipher Prostate Genomic Classifier is the ...
Allogeneic Vaccination With a B7.1 HLA-A Gene-Modified Adenocarcinoma Cell Line in Patients With Advanced Non–Small-Cell Lung Cancer The incidence of prostate cancer is frequent, occurring in almost ...
A genetic variant implicated in several cancers by genome-wide association studies (GWAS) has been found to drive increased expression of a known oncogene in the prostate. The study, published July ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback